BioVaxys Technology Corp. (CSE:BIOV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0500
-0.0050 (-9.09%)
Mar 28, 2025, 3:59 PM EST

BioVaxys Technology Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2019
Selling, General & Admin
2.822.122.344.120.42
Upgrade
Research & Development
00.130.960.730.24
Upgrade
Operating Expenses
3.122.43.85.981.01
Upgrade
Operating Income
-3.12-2.4-3.8-5.98-1.01
Upgrade
Interest & Investment Income
---00
Upgrade
Currency Exchange Gain (Loss)
-0-0.03-0.02-0.02-0
Upgrade
Other Non Operating Income (Expenses)
-0.17-4.03-0.26-0.46-0.09
Upgrade
EBT Excluding Unusual Items
-3.3-6.46-4.08-6.46-1.1
Upgrade
Asset Writedown
-1.29-1.45-7.4--
Upgrade
Other Unusual Items
0.630.21-0.25--
Upgrade
Pretax Income
-3.95-7.69-11.73-6.46-1.1
Upgrade
Earnings From Continuing Operations
-3.95-7.69-11.73-6.46-1.1
Upgrade
Earnings From Discontinued Operations
-----0.07
Upgrade
Net Income
-3.95-7.69-11.73-6.46-1.17
Upgrade
Net Income to Common
-3.95-7.69-11.73-6.46-1.17
Upgrade
Shares Outstanding (Basic)
196134988328
Upgrade
Shares Outstanding (Diluted)
196134988328
Upgrade
Shares Change (YoY)
45.90%36.63%18.39%193.97%171.65%
Upgrade
EPS (Basic)
-0.02-0.06-0.12-0.08-0.04
Upgrade
EPS (Diluted)
-0.02-0.06-0.12-0.08-0.04
Upgrade
EBIT
-3.12-2.4-3.8-5.98-1.01
Upgrade
Advertising Expenses
0.42-0.171.720.08
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.